| Bioactivity | Fmoc-KCRGDK is a self-assembling peptide that can be used to prepare hydrogels and assist in drug delivery for immune checkpoint inhibitors. Fmoc-KCRGDK can be applied in cancer immunotherapy research[1]. |
| Sequence | {Fmoc}-Lys-Cys-Arg-Gly-Asp-Lys |
| Shortening | {Fmoc}-KCRGDK |
| Formula | C42H61N11O11S |
| Molar Mass | 928.07 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Falcone N, et al. Peptide Hydrogels as Immunomaterials and Their Use in Cancer Immunotherapy Delivery. Adv Healthc Mater. 2023 Oct;12(27):e2301096. |